Novartis may give away a new drug with a price tag above $2 million for free to some patients using a lottery-style program. The drug, Zolgensma, is a cure for a deadly inherited disease, spinal muscular atrophy, and the world’s most expensive drug.

Humana’s top executives offloaded a significant sum of shares in late December, shedding about 107,077 Humana shares worth $37.7 million, Louisville Business First reported.

Cigna, one of the nation’s largest health insurance providers, has agreed to sell its group disability and life insurance business to New York Life for a purchase price of $6.3 billion.

The individual mandate of the Affordable Care Act, which requires individuals to have health insurance coverage or face a penalty, has been declared unconstitutional by the Fifth Circuit Court. The ruling is a victory for the Republican-led lawsuit to overturn the ACA. However, it still leaves other elements of the ACA without a decision, including the popular provision of healthcare coverage for those with pre-existing conditions.

The Trump administration, along with HHS and the FDA, have issued a notice of proposed rulemaking (NRPM) for a drug importation plan to allow certain drugs to be purchased from Canada.

AI could change healthcare forever. But for the technology to reach its full potential, researchers must make sure they go about things the right way.

Medical debt is a significant factor in the reasons Americans file for bankruptcy, and Americans facing major health scares are also likely to face financial setbacks.

A CVS Health subsidiary, Omnicare, is facing a lawsuit from the Department of Justice over allegations the company defrauded government health programs by providing prescription drugs to thousands of long-term care facilities without proper prescriptions.